Secondary research
300+early-stage drugs analyzed
Map the programs
We built competitive landscapes of early-stage programs focused on targets of interest.
Case Study · Opportunity Assessment
Finding the next wave in neuroscience.
A global biopharmaceutical company wanted opportunities to complement its neuroscience pipeline in epilepsy, ALS and AI for drug discovery. We analyzed over 300 early-stage drugs, interviewed experts and shortlisted 10 potential partners.
The Client
The client is a global biopharmaceutical company with an active neuroscience pipeline. It wanted to find programs and partners that could complement that pipeline.
The Challenge
Crowded pipelines.
Find the right programs.
Prescouter was asked to evaluate opportunities to complement the client’s neuroscience pipeline through a series of landscapes on epilepsy, ALS and AI and machine learning for drug discovery.
-
Epilepsy
Epilepsy programs
Early-stage assets and targets.
-
ALS
ALS programs
Unmet needs and new approaches.
-
AI/ML
AI drug discovery
Partners for smarter discovery.
Our Approach
Pairing pipeline landscapes with expert insight.
Expert interviews
Multipleexperts interviewed
Read the trends
Experts explained developments, unmet needs and challenges in each therapeutic space.
Partner outreach
10AI partners shortlisted
Test openness
We contacted companies of interest to gauge partnership openness and learn about their programs.
The Outcome
A roadmap of partnering options.
Prescouter delivered program landscapes in epilepsy and ALS covering over 300 early-stage drugs, informing both discovery and commercial teams. A curated shortlist of 10 AI and machine learning partners gave the client a clear roadmap, with insights that also supported oncology and immunology business development.
-
Landscape
300+ early-stage drugs
Across epilepsy and ALS.
-
Partners
10 AI/ML candidates
Shortlisted for evaluation.
-
Reach
Beyond neuroscience
Also informing oncology and immunology.
Early-stage programs move fast, and the best partners are rarely obvious. Combining landscapes with expert views and outreach sharpens strategic priorities.
Let’s Talk
Which programs could strengthen your pipeline?
Let us map the programs and partners that fit your strategy. Wherever you’re starting from, we’ll help you get there.
Or email [email protected]